Revelation Biosciences Files S-1 for Potential Stock Offering
Ticker: REVBW · Form: S-1 · Filed: May 20, 2025 · CIK: 1810560
| Field | Detail |
|---|---|
| Company | Revelation Biosciences, Inc. (REVBW) |
| Form Type | S-1 |
| Filed Date | May 20, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: ipo-filing, registration-statement, biotech
TL;DR
Revelation Biosciences just filed an S-1, looks like they're gearing up to sell stock. 🚀
AI Summary
Revelation Biosciences, Inc. filed an S-1 registration statement on May 20, 2025, indicating plans to offer securities. The company, formerly known as Petra Acquisition Inc. until April 23, 2020, is incorporated in Delaware and headquartered in San Diego, California. This filing is part of the process for Revelation Biosciences to potentially raise capital through the sale of its stock.
Why It Matters
This S-1 filing signals Revelation Biosciences' intention to access public markets, which could provide capital for its operations and growth, impacting its future development and potential investor returns.
Risk Assessment
Risk Level: medium — As a company filing an S-1, Revelation Biosciences is likely in an early stage of development or seeking significant funding, which inherently carries higher risks than established, profitable companies.
Key Numbers
- 333-287423 — SEC File Number (Identifies this specific registration statement with the SEC.)
- 0001810560 — Central Index Key (Unique identifier for Revelation Biosciences, Inc. in SEC filings.)
Key Players & Entities
- REVELATION BIOSCIENCES, INC. (company) — Registrant
- Petra Acquisition Inc. (company) — Former company name
- 20200423 (date) — Date of name change
- 20250520 (date) — Filing date
- 4660 La Jolla Village Drive, Suite 100, San Diego, CA 92122 (address) — Principal executive offices
- James Rolke (person) — Chief Executive Officer
FAQ
What is the primary purpose of this S-1 filing for Revelation Biosciences, Inc.?
The S-1 filing is a registration statement required by the SEC for companies planning to offer securities to the public, indicating Revelation Biosciences' intent to potentially raise capital.
When was Revelation Biosciences, Inc. previously known by another name?
Revelation Biosciences, Inc. was formerly known as Petra Acquisition Inc. until April 23, 2020.
Where is Revelation Biosciences, Inc. headquartered?
The company's principal executive offices are located at 4660 La Jolla Village Drive, Suite 100, San Diego, CA 92122.
What is the SEC file number associated with this S-1 filing?
The SEC file number for this registration statement is 333-287423.
Who is the Chief Executive Officer of Revelation Biosciences, Inc. mentioned in the filing?
James Rolke is identified as the Chief Executive Officer of Revelation Biosciences, Inc.
Filing Details
This Form S-1 (Form S-1) was filed with the SEC on May 20, 2025 by James Rolke regarding REVELATION BIOSCIENCES, INC. (REVBW).